Shanxun Yu

543 total citations
6 papers, 367 citations indexed

About

Shanxun Yu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shanxun Yu has authored 6 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Cancer Research and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Shanxun Yu's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and RNA Research and Splicing (4 papers). Shanxun Yu is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers) and RNA Research and Splicing (4 papers). Shanxun Yu collaborates with scholars based in China and United States. Shanxun Yu's co-authors include Zhaoxia Wang, Chenchen Wei, Zhenyao Chen, Fengqi Nie, Qinnan Chen, Shuai Yan, Tianwei Xu, Shengnan Ren, Pei Ma and Ming Sun and has published in prestigious journals such as Clinical Cancer Research, Cell Death and Disease and Cancer Science.

In The Last Decade

Shanxun Yu

6 papers receiving 364 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shanxun Yu China	5	340	339	23	19	16	6	367
Shuzhi Zang China	7	297 0.9×	290 0.9×	24 1.0×	27 1.4×	16 1.0×	8	333
Miaojun Zhu China	4	376 1.1×	403 1.2×	22 1.0×	42 2.2×	17 1.1×	6	436
Wei-zhao Peng China	4	313 0.9×	306 0.9×	20 0.9×	11 0.6×	16 1.0×	6	348
Zuoyang Zhang China	6	297 0.9×	270 0.8×	30 1.3×	18 0.9×	23 1.4×	8	346
Serena Di Cecilia United States	4	441 1.3×	331 1.0×	19 0.8×	15 0.8×	33 2.1×	4	495
Julia Humberg Germany	3	478 1.4×	476 1.4×	41 1.8×	29 1.5×	23 1.4×	5	524
Linguo Xu China	4	252 0.7×	248 0.7×	25 1.1×	28 1.5×	19 1.2×	4	304
Nandi Li China	10	317 0.9×	341 1.0×	42 1.8×	16 0.8×	17 1.1×	14	371
Miaomiao Sun China	5	191 0.6×	169 0.5×	18 0.8×	11 0.6×	18 1.1×	14	229

Countries citing papers authored by Shanxun Yu

Since Specialization

Citations

This map shows the geographic impact of Shanxun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanxun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanxun Yu more than expected).

Fields of papers citing papers by Shanxun Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanxun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanxun Yu. The network helps show where Shanxun Yu may publish in the future.

Co-authorship network of co-authors of Shanxun Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Shanxun Yu. A scholar is included among the top collaborators of Shanxun Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanxun Yu. Shanxun Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Yu, Shanxun, et al.. (2024). Epithelial–Mesenchymal Transition in Non-Small Cell Lung Cancer Management: Opportunities and Challenges. Biomolecules. 14(12). 1523–1523. 3 indexed citations

2.

Gu, Jingyao, Pei Liu, Wang He, et al.. (2020). <p>Long Non-Coding RNA SPRY4-IT1 Reverses Cisplatin Resistance by Downregulating MPZL-1 via Suppressing EMT in NSCLC</p>. OncoTargets and Therapy. Volume 13. 2783–2793. 17 indexed citations

3.

Yu, Shanxun, et al.. (2019). Long noncoding RNA actin filament‐associated protein 1 antisense RNA 1 promotes malignant phenotype through binding with lysine‐specific demethylase 1 and repressing HMG box‐containing protein 1 in non‐small‐cell lung cancer. Cancer Science. 110(7). 2211–2225. 23 indexed citations

4.

Xu, Tianwei, Shuai Yan, Lihua Jiang, et al.. (2019). Gene Amplification-Driven Long Noncoding RNA SNHG17 Regulates Cell Proliferation and Migration in Human Non-Small-Cell Lung Cancer. Molecular Therapy — Nucleic Acids. 17. 405–413. 49 indexed citations

5.

Chen, Xin, Zhenyao Chen, Shanxun Yu, et al.. (2018). Long Noncoding RNA LINC01234 Functions as a Competing Endogenous RNA to Regulate CBFB Expression by Sponging miR-204-5p in Gastric Cancer. Clinical Cancer Research. 24(8). 2002–2014. 183 indexed citations

6.

Chen, Zhenyao, Xin Chen, Ping Chen, et al.. (2017). Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression. Cell Death and Disease. 8(10). e3092–e3092. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact